A case developing minimal change disease during the course of IgG4-related disease

Kazunori Yamada1,2, Takeshi Zoshima1, Kiyoaki Ito1

  • 1a Division of Rheumatology, Kanazawa University Graduate School of Medicine , Kanazawa , Ishikawa , Japan.

Modern Rheumatology
|March 5, 2015
PubMed

Insights

Immunoglobulin G4-related disease (IgG4-RD) can present with minimal change disease (MCD), a rare kidney disorder. This case highlights a potential link, suggesting shared immune pathways may contribute to both conditions.

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Immunoglobulin G4-related disease (IgG4-RD) is a multisystem fibroinflammatory condition.
  • Minimal change disease (MCD) is a common cause of nephrotic syndrome in adults.
  • The co-occurrence of IgG4-RD and MCD is infrequently reported.

Observation:

  • A 66-year-old male with a history of IgG4-RD developed sudden massive proteinuria and weight gain, indicative of nephrotic syndrome.
  • Laboratory results showed no elevation in serum IgG4 levels or hypocomplementemia.
  • Renal biopsy findings were consistent with Minimal Change Disease, including foot process effacement on electron microscopy.

Findings:

  • The patient was diagnosed with Minimal Change Disease (MCD) despite having a history of IgG4-related disease (IgG4-RD).
  • Treatment with prednisolone rapidly resolved proteinuria, confirming the diagnosis of MCD.
  • The absence of elevated IgG4 or hypocomplementemia in this presentation is noteworthy.

Implications:

  • The shared T-helper 2-dominant immunoreaction between IgG4-RD and MCD suggests a potential pathophysiological link.
  • This case underscores the importance of considering MCD in IgG4-RD patients presenting with nephrotic syndrome.
  • Further research into the immunological overlap may reveal novel therapeutic targets for both conditions.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.6K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
951
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
994
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
726